UBS Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-627,973
| Closed | -$433K | – | 8643 |
|
|
2020
Q4 | $433K | Sell |
627,973
-60,621
| -9% | -$41.8K | ﹤0.01% | 3773 |
|
|
2020
Q3 | $1.55M | Sell |
688,594
-229,288
| -25% | -$516K | ﹤0.01% | 2620 |
|
|
2020
Q2 | $3.29M | Sell |
917,882
-4,517,312
| -83% | -$16.2M | ﹤0.01% | 1901 |
|
|
2020
Q1 | $20.7M | Buy |
5,435,194
+132,446
| +2% | +$503K | 0.01% | 759 |
|
|
2019
Q4 | $16M | Buy |
+5,302,748
| New | +$16M | 0.01% | 1184 |
|